Pet medicine report lookup / Milbemycin Oxime / Dogs

What has been reported to the FDA for Milbemycin Oxime in dogs?

Short answer: The FDA has received 179,859 adverse event reports for dogs that name Milbemycin Oxime. The FDA lists 7 approved animal drug applications containing Milbemycin Oxime for dogs, the earliest approved in 1990. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Milbemycin Oximein dogs
179,859reports to the FDA

The FDA has received 179,859 adverse event reports for dogs that name Milbemycin Oxime.

  1. 179,859 reports name Milbemycin Oxime in dogs, which is 18% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
  2. 14% are marked serious and 2.7% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
  3. 32% are complaints that the product did not work (38% across all dog reports).
  4. The clinical signs reported most are emesis, vomiting and lethargy.
  5. The FDA lists 7 approved animal drug applications containing Milbemycin Oxime for dogs, the earliest approved in 1990.
  6. None of this is a rate. The FDA data does not record how many dogs were given Milbemycin Oxime, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll dog reports
Marked seriousthe FDA record flags the report as serious24,56314%29%
Death or euthanasiathe outcome recorded in the report, with no finding of cause4,9262.7%5.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event57,58232%38%
Seizurea seizure or convulsion is among the clinical signs6,0863.4%4.4%
Not used per labelthe report says the product was not used the way its label directs30,16317%21%

Where on the body do the reported signs sit?

50%5.5%

Not on the body: Did not work 27% Whole body 9.8% How it was given 2.5%

  1. Stomach and gut50%emesis, vomiting, diarrhoea, not eating and 5 more
  2. Did not work27%lack of efficacy (endoparasite) - heartworm, lack of efficacy, ineffective, heartworm larvae, lack of efficacy (ectoparasite) - flea and 3 more
  3. Whole body9.8%lethargy
  4. Brain and nerves5.5%seizure, ataxia, shaking
  5. How it was given2.5%overdose, unpalatable
  6. Behaviour2.2%behavioural disorder
  7. Blood and organ tests2.1%other abnormal test result
  8. Skin and coat1.2%itching

Each figure is a share of sign mentions among the 25 signs reported most for Milbemycin Oxime in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Emesis42,909 24%
  2. Vomiting39,112 22%
  3. Lethargy21,870 12%
  4. Lack of efficacy (endoparasite) - heartworm14,250 7.9%
  5. Lack of efficacy13,047 7.2%
  6. Diarrhoea10,832 6.0%
  7. INEFFECTIVE, HEARTWORM LARVAE9,080 5.1%
  8. Lack of efficacy (ectoparasite) - flea7,669 4.3%

Reports received per year

24,53802012: 23,015 reports2013: 24,538 reports2014: 20,233 reports2015: 17,473 reports2016: 14,943 reports2017: 14,084 reports2018: 13,542 reports2019: 12,857 reports2020: 10,163 reports2021: 6,655 reports2022: 4,847 reports2023: 4,225 reports2024: 4,391 reports2025: 3,490 reports2026: 1,376 reports20122014201620182020202220242026
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 24,538 reports (2013). The earliest FDA approval for dogs was in 1990.

Is it approved for dogs?

DogsFDA-approved product listed
CatsFDA-approved product listed
Other animalsnone found
FDA-approved for dogs

The FDA lists 7 approved animal drug applications containing Milbemycin Oxime for dogs, the earliest approved in 1990.

ProductFormApproved forFirst approvedFDA application
InterceptorElanco US Inc.Tablet RXCat, Dog1990140-915
Sentinel Flavor TabsIntervet, Inc.Tablet RXDog1997141-084
Sentinel Flavor Tabs And Capstar Flea Management SystemIntervet, Inc.Tablet RXDog2003141-204
TrifexisElanco US Inc.Chewable Tablets RXDog2011141-321
Sentinel SpectrumIntervet, Inc.Chewable Tablets RXDog2011141-333
Interceptor PlusElanco US Inc.Chewable Tablets RXDog2012141-338
MilbeguardCeva Sante AnimaleFlavored Tablets RXCat, Dog2018200-629

From the FDA record for Interceptor: Do not use in kittens less than 6 weeks of age or 1.5 pounds body weight. Administer once a month. Federal law restricts this drug to use by or on the order of a licensed veterinarian.Safety in heartworm-positive cats has not been established. Safety in breeding, pregnant, and lactating queens and breeding toms has not been established.

What can you do next?

Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save